Patient Assessment & Care Planning Flashcards
7 cards from real MTM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Patient Assessment & Care Planning flashcards as text
A patient taking lithium reports increased thirst, frequent urination, and hand tremors. During assessment, the pharmacist notes a lithium level of 1.6 mEq/L. What is the most appropriate care plan action?
Answer: Classify this as an adverse drug reaction due to toxicity and recommend urgent prescriber contact
A lithium level of 1.6 mEq/L exceeds the therapeutic range of 0.6–1.2 mEq/L, and toxicity symptoms confirm an adverse drug reaction requiring urgent intervention.
When gathering a medication history during patient assessment, which source provides the most complete and accurate picture of current medications?
Answer: A brown bag review combined with pharmacy records and patient interview
A brown bag review combined with pharmacy records and a thorough patient interview captures prescription, OTC, and herbal medications across all providers.
An MTM patient taking warfarin reports she started taking St. John's Wort for low mood. What drug therapy problem does this represent?
Answer: Adverse drug reaction due to a drug-herb interaction reducing warfarin efficacy
St. John's Wort induces CYP2C9 and P-glycoprotein, reducing warfarin levels and increasing thromboembolic risk, representing a clinically significant drug-herb interaction.
In the Pharmacists' Patient Care Process (PPCP), which step directly follows 'Collect'?
Answer: Assess
The PPCP sequence is Collect → Assess → Plan → Implement → Follow-up and Monitor, making Assess the step that directly follows data collection.
A newly diagnosed hypertensive patient refuses to start amlodipine due to fear of side effects. How should the pharmacist address this in the care plan?
Answer: Explore the patient's concerns using motivational interviewing, provide education, and document the barrier
Patient-centered care requires exploring concerns, providing accurate information, and documenting barriers to treatment as part of the collaborative care plan.
Which of the following lab values is most relevant when assessing the safety of prescribing an ACE inhibitor in a patient with chronic kidney disease?
Answer: Serum potassium and creatinine/eGFR
ACE inhibitors can cause hyperkalemia and may affect renal function, making serum potassium and eGFR critical safety parameters in CKD patients.
A pharmacist completes an MTM session and documents a personal medication record (PMR). What distinguishes the PMR from the medication action plan (MAP)?
Answer: The PMR is a comprehensive list of all the patient's medications, while the MAP outlines patient self-care actions
The PMR is a complete medication list given to the patient for reference, while the MAP is a prioritized action list of steps the patient should take to improve their health.